Swarnima Singh

Employment

• Icahn School of Medicine at Mount Sinai
• Baylor College of Medicine

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (25)

• Supplementary Figures from Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2− Breast Cancer
  2026 DOI: 10.1158/2159-8290.32701726
  +Save
• Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2− Breast Cancer
  Cancer Discovery 2025 DOI: 10.1158/2159-8290.CD-23-0543
  +Save
• Data from Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2− Breast Cancer
  2025 DOI: 10.1158/2159-8290.c.7749825
  +Save
• Supplementary Figures from Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2− Breast Cancer
  2025 DOI: 10.1158/2159-8290.28713546
  +Save
• Organ-specific roles of CD83+macrophages in breast cancer
  CANCER RESEARCH 2024 DOI: 10.1158/1538-7445.AM2024-LB314
  +Save
• Data from Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer
  2023 DOI: 10.1158/0008-5472.c.6513992.v1
  +Save
• Data from Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer
  2023 DOI: 10.1158/0008-5472.c.6513992
  +Save
• Supplementary Data from Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer
  2023 DOI: 10.1158/0008-5472.22431800.v1
  +Save
• Supplementary Data from Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer
  2023 DOI: 10.1158/0008-5472.22431800
  +Save
• Supplementary Data from Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer
  2023 DOI: 10.1158/0008-5472.22431803.v1
  +Save